May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
The Incidence of Noninfectious Endophthalmitis After Intravitreal Preservative-Free Triamcinolonce Acetonide
Author Affiliations & Notes
  • O. M. Krajnyk
    Department of Ophthalmology, Robert Wood Johnson Medical School - University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey
  • D. B. Roth
    Department of Ophthalmology, Robert Wood Johnson Medical School - University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey
  • J. Prenner
    Department of Ophthalmology, Robert Wood Johnson Medical School - University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey
  • Footnotes
    Commercial Relationships O.M. Krajnyk, None; D.B. Roth, None; J. Prenner, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 247. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      O. M. Krajnyk, D. B. Roth, J. Prenner; The Incidence of Noninfectious Endophthalmitis After Intravitreal Preservative-Free Triamcinolonce Acetonide. Invest. Ophthalmol. Vis. Sci. 2007;48(13):247.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: The use of off-label intravitreal trimacinolone acetonide (IVTA) has raised a concern regarding noninfectious endophthalmitis and inflammatory reactions associated with the drug. We sought to determine whether the use of preservative-free triamcinolone acetonide for intravitreal injection would reduce the incidence of this form of endophthalmitis.

Methods:: After extensive experience with the use of KENALOG®-40 for intravitreal injection, we switched to the exclusive use of preservative-free triamcinolone acetonide, obtained from a commercial compounding pharmacy. Single-dose vials were obtained and no manipulation of the drug, removal of supernatant, filtering or washing was performed. We reviewed the medical records of all patients receiving preservative-free IVTA from July 1, 2006 through Nov 14, 2006. Demographic information and details of post-injection inflammation or endophthalmitis were collected.

Results:: 326 patients were identified who received a total of 380 IVTA injections. Nine eyes (2.3%) of nine patients (2.8%) were identified that experienced an inflammatory reaction after preservative-free IVTA. Endophthalmitis with obscuration of all fundus details was observed in 6 eyes and moderate inflammation was noted in 3 eyes. An inflammatory hypopyon distinct from triamcinolone particles was seen in 7 eyes. Seven eyes were pseuophakic and 2 were phakic. In pseudophakic eyes, the capsule was intact in 4 eyes. The indication for IVTA was post-operative CME in 66.7% of eyes experiencing noninfectious endophthalmitis. Seven of the nine cases resolved spontaneously without intervention. Two of the nine cases were cultured and received intraocular antibiotics due to a concern for infectious endophthalmitis. Both of these cultures had no growth.

Conclusions:: Preservative-free triamcinolone acetonide does not seem to reduce the incidence of post-injection inflammatory reactions. Post-IVTA noninfectious endophthalmitis appears to be more common in eyes being treated for post-operative cystoid macular edema.

Keywords: endophthalmitis • retina • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×